Cancer epigenetics
- Submission status
- Open
- Submission deadline
The role of epigenetic mechanisms, such as DNA or RNA methylation, histone modifications, nucleosome changes, and non-coding RNAs in cancer has gained increasing interest in recent studies. The reversible nature of epigenetic changes holds promise for the development of epigenetic therapeutic approaches and several of them have been approved for clinical use so far.
With this cross-journal Collection, the editors at Nature Communications, Communications Biology, Communications Medicine and Scientific Reports invite submissions covering the breadth of research carried out in the field of cancer epigenetics. We will highlight studies aiming at the improvement of our understanding of the epigenetic mechanisms underlying cancer initiation, progression, response to therapy, metastasis and tumour plasticity as well as findings that have the potential to be translated into the clinic.
This Collection is open for submissions from all authors – and not by invitation only – on the condition that the manuscripts fall within the scope of the Collection and the participating journals more generally.
All manuscripts will be considered for publication according to the editorial policies of the specific participating journal through which they are submitted. Visit Nature portfolio’s Collections guidelines for more details.
When submitting your manuscript to a participating journal via our online submission system, please choose the appropriate Collection title from the drop-down menu on the submission form. Please be sure to express your interest in the Collection in your cover letter. Please only submit to one journal, but note authors have the option to transfer to another participating journal following the editors’ recommendation.
This Collection has not been supported by sponsorship.
